Recent Updates
Recently added Catalysts
IMRN Positive Sentiment Score: 70/100

Immuron CEO Steven Lydeamore Investor Webinar Presentation

Monday, November 13, 2023 1 min read
Key Takeaway: Immuron Limited is hosting an investor webinar on November 14, 2023, led by CEO Steven Lydeamore. During the session, he will discuss the company's business updates and upcoming milestones. Shareholders will have a chance to participate in a moderated Q&A after the presentation. A recording will be made available on the company’s website after the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • The investor webinar will provide key updates on business milestones.
  • Opportunity for shareholders to engage directly with CEO Steven Lydeamore.
  • The company focuses on developing targeted polyclonal antibodies.

Full Press Release Details

MELBOURNE, Australia, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to invite shareholders to attend an investor webinar on The Watchlist, to be held on Tuesday, 14th November, 2023, 1:00pm AEDT/10:00am AWST.
CEO Steven Lydeamore will provide an overview and update on the business and upcoming milestones.
Following the presentation, attendees will have the opportunity to ask questions directly to Mr Lydeamore during a moderated Q & A session.
This webinar can be viewed live via zoom & you register via the link below.
Zoom: https://share.hsforms.com/1ccfJimCATYqzCkvIKIC7VAd16zr
A recorded copy of the webinar and presentation will be available on the Company’s website following the event.
Authorised for release by the Board of Immuron Limited.
Immuron Limited (ASX: IMC, NASDAQ: IMRN) is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.
For more information visit: http://www.immuron.com

Tags

Frequently Asked Questions

When is the Immuron investor webinar scheduled?

The investor webinar is scheduled for November 14, 2023, at 1:00pm AEDT.

Who will present during the investor webinar?

CEO Steven Lydeamore will present an update on the business.

Can attendees ask questions during the webinar?

Yes, there's a moderated Q&A session for attendees to ask questions.

How can I access the webinar?

You can access the webinar live via Zoom; registration is required.

Will the webinar be available for later viewing?

Yes, a recorded version will be available on the company's website afterward.

Tags: IMRN Viatris Investor Conferences Healthcare Immuron Steven Lydeamore polyclonal antibodies biopharmaceutical company
Last updated: Nov 13, 2023